Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents

被引:78
作者
Gao, Chunmei [1 ,2 ,3 ]
Li, Bin [1 ,2 ]
Zhang, Bin [1 ,2 ]
Sun, Qinsheng [2 ]
Li, Lulu [2 ]
Li, Xi [1 ,2 ]
Chen, Changjun [1 ,2 ]
Tan, Chunyan [2 ,3 ]
Liu, Hongxia [2 ,3 ]
Jiang, Yuyang [2 ,3 ,4 ]
机构
[1] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China
[2] Shenzhen Key Lab Chem Biol, Minist Prov Jointly Constructed Base State Key La, Shenzhen 518055, Peoples R China
[3] Tsinghua Univ, Grad Sch Shenzhen, Natl & Local United Engn Lab Personalized Antitum, Shenzhen 518055, Peoples R China
[4] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China
关键词
Acridine; Benzimidazole; DNA; Topoisomerase I; Antitumor; ANTITUMOR-ACTIVITY; ANTICANCER AGENTS; TOPOISOMERASE; INHIBITORS; SCAFFOLD; ANALOGS; TARGET;
D O I
10.1016/j.bmc.2015.02.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of new effective DNA-targeted antitumor agent is needed because of their clinical significance. As acridines can intercalate into DNA and benzimidazoles have the ability to bind in the DNA minor groove, a series of novel benzimidazole acridine derivatives were designed and synthesized to be new DNA-targeted compounds. MTT assay indicated that most of the synthesized compounds displayed good antiproliferative activity, among which compound 8l demonstrated the highest activity against both K562 and HepG-2 cells. Further experiments showed that 8l displayed good DNA-binding capability and inhibited topoisomerase I activity. Moreover, compound 8l could induce apoptosis in K562 cell lines through mitochondrial pathway. These data suggested that compound 8l might be potential as new DNA-binding and apoptosis-inducing antitumor agents. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1800 / 1807
页数:8
相关论文
共 28 条
  • [1] Barot KP, 2013, MINI-REV MED CHEM, V13, P1421
  • [2] Barot KP, 2013, MINI-REV MED CHEM, V13, P1239
  • [3] Acridine/acridone: a simple scaffold with a wide range of application in oncology
    Belmont, Philippe
    Dorange, Ismet
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (11) : 1211 - 1224
  • [4] Acridine and acridone derivatives, anticancer properties and synthetic methods: Where are we now?
    Belmont, Philippe
    Bosson, Johann
    Godet, Thomas
    Tiano, Martin
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 139 - 169
  • [5] PREPARATION OF SOME BENZIMIDAZOLYLAMINO ACIDS - REACTIONS OF AMINO ACIDS WITH O-PHENYLENEDIAMINES
    CESCON, LA
    DAY, AR
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1962, 27 (02) : 581 - &
  • [6] Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis
    Cholewinski, Grzegorz
    Dzierzbicka, Krystyna
    Kolodziejczyk, Aleksander M.
    [J]. PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 305 - 336
  • [7] New substituted benzimidazole derivatives: a patent review (2010-2012)
    Fei, Fan
    Zhou, Zhiming
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (09) : 1157 - 1179
  • [8] Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
    Gaba, Monika
    Singh, Sarbjot
    Mohan, Chander
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 76 : 494 - 505
  • [9] Galdino-Pitta MR, 2013, MINI-REV MED CHEM, V13, P1256
  • [10] Synthesis and evaluation of 10-(3,5-dimethoxy)benzyl-9(10H)-acridone derivatives as selective telomeric G-quadruplex DNA ligands
    Gao, Chunmei
    Li, Shangfu
    Lang, Xuliang
    Liu, Hongxia
    Liu, Feng
    Tan, Chunyan
    Jiang, Yuyang
    [J]. TETRAHEDRON, 2012, 68 (38) : 7920 - 7925